The American Journal of Managed Care8d
FDA Approves First Subcutaneous Apomorphine Device for Parkinson Disease
The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...
Rutgers University15d
A Weekly Injection Could Replace Painful Daily Treatment for Rare Fat Disorder
“When you inject yourself with, for example, insulin, you inject into subcutaneous fat, but these patients don’t have that,” ...
Cure Today24d
The Significance of the Subcutaneous Opdivo FDA Approval in Solid Tumors
The Dec. 27, 2024, Food and Drug Administration (FDA) approval of the subcutaneous injection formulation of Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) for patients with solid tumors opened up ...
Cure Today29d
The Subcutaneous Approval of Opdivo Makes Waves in Future of Cancer Care
Most recently, the Food and Drug Administration (FDA) approved treatment with the subcutaneous injection formulation of Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) for patients with solid tumors ...